Platinum-Based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer - Related Studies

Platinum-Based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer

This study is ongoing, but not recruiting participants.

Study NCT00002894. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Ovarian Cancer
		Peritoneal Cavity Cancer

2	Additional conditions recognized in this trial
		Ovarian Neoplasms

3	More general conditions related to this trial
		Adnexal Diseases
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Genital Diseases, Female
		Genital Neoplasms, Female
		Gonadal Disorders
		Neoplasms
		Neoplasms by Site
		Ovarian Diseases
		Urogenital Neoplasms

4	Interventions listed in this trial
		carboplatin
		cisplatin
		paclitaxel

5	More general drug interventions related to this trial
		Antimitotic Agents
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Mitosis Modulators
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses
		Tubulin Modulators

6	Sponsors listed in this trial
		Medical Research Council